1. Home
  2. TREE vs ZURA Comparison

TREE vs ZURA Comparison

Compare TREE & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LendingTree Inc.

TREE

LendingTree Inc.

HOLD

Current Price

$41.72

Market Cap

587.3M

Sector

Finance

ML Signal

HOLD

Logo Zura Bio Limited

ZURA

Zura Bio Limited

HOLD

Current Price

$5.93

Market Cap

521.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TREE
ZURA
Founded
1996
2022
Country
United States
United States
Employees
N/A
30
Industry
Finance: Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
587.3M
521.8M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
TREE
ZURA
Price
$41.72
$5.93
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
9
Target Price
$71.25
$11.78
AVG Volume (30 Days)
377.6K
475.6K
Earning Date
03-02-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
443.31
N/A
EPS
10.78
N/A
Revenue
$1,117,324,000.00
N/A
Revenue This Year
$19.03
N/A
Revenue Next Year
$6.92
N/A
P/E Ratio
$4.03
N/A
Revenue Growth
24.12
N/A
52 Week Low
$32.65
$0.99
52 Week High
$77.35
$7.25

Technical Indicators

Market Signals
Indicator
TREE
ZURA
Relative Strength Index (RSI) 46.36 46.38
Support Level $39.04 $5.62
Resistance Level $50.94 $6.99
Average True Range (ATR) 1.83 0.49
MACD 0.48 -0.09
Stochastic Oscillator 46.34 34.16

Price Performance

Historical Comparison
TREE
ZURA

About TREE LendingTree Inc.

LendingTree Inc. is a U.S.-based company that mainly operates an online loan marketplace. The company offers online tools and resources to help consumers find loans or other credit-based products, including mortgage loans, reverse mortgages, home equity loans, personal loans, auto loans, credit cards, student loans, small business loans, and various related products. It provides consumers with direct access to a wide array of lenders. The company has three reportable segments: Home, Consumer, and Insurance. It generates match fees by connecting consumers with lenders and closing fees from lenders when a transaction is finalized. The company conducts business solely in the United States.

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

Share on Social Networks: